title,"Sponsors / Collaborators","Phase of Development","Clinical Trial Link","Mechanism of Action","Populations Tested In","FDA Designation","Nonprofit/Government Support","Presented at meetings",Location,"Mechanism Description","Phase of Development Devices","Type of Drug/Device",field_type_of_device_technique,US,"ct description",Software/Hardware/Both,"ex-US Approval","Year on Market" "ZX008 (Fenfluoramine)",Zogenix,"Phase 3","https://ClinicalTrials.gov/show/NCT02926898, https://ClinicalTrials.gov/show/NCT02655198, https://www.epilepsy.com/clinical_trials/fenfluramine-assessment-rare-epilepsy-…",Serotonin,"Dravet Syndrome",,N/A,"AEDD XV - May 2019",N/A,": Modulating Serotonin",,,,,,N/A,,